Per, we emphasize pioglitazone and telmisartan as distinctive ligands for the NSCLC repressor PPARG in the current in-silico targeted delivery investigation; therefore, we will use chem-bio-informatics35 to find out how well the chosen drugs work for treating lung cancer when delivered by exosome cargo, before testing them in the lab. Here, PPARG is linked to lung cancer.